Nestle's Nine-Month Organic Sales Growth Missed Expectations—Update
By Giulia Petroni
Nestle posted a lower-than-expected organic sales growth in the first nine months of the year and confirmed its outlook.
The Swiss food and beverage giant said sales stood at 68.83 billion Swiss francs ($76.57 billion) in the period from CHF69.13 billion a year earlier. Sales grew 7.8% organically, missing a company-compiled consensus estimate of 8.1%.
Organic growth was driven by pricing at 8.4%, while real internal growth--the sum of volume and mix--came in line with expectations at minus 0.6%.
"Growth was driven by pricing as we continued to navigate historic inflation levels. The recovery of our volume and mix is underway," Chief Executive Mark Schneider said.
Nestle said it expects real internal growth to turn positive in the second half.
The company confirmed its full-year guidance for organic sales growth of between 7% and 8%, and underlying trading operating profit margin between 17% and 17.5%. Underlying earnings per share in constant currency are expected to increase between 6% and 10%.
Write to Giulia Petroni at giulia.petroni@wsj.com
(END) Dow Jones Newswires
October 19, 2023 02:17 ET (06:17 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Q3 2024 Stock Market Outlook: Is the AI Stock Trade Over?
-
Ian Bremmer: 4 Big Geopolitical Risks to Watch
-
What’s Happening In the Markets This Week
-
Obesity Drug Stocks: Why It Will Be ‘Exceptionally Difficult’ to Dethrone Eli Lilly and Novo Nordisk
-
What Does Chipotle’s Stock Split Mean for Investors?
-
5 Stocks to Buy Before the Fed Cuts Interest Rates in 2024
-
Markets Brief: Inflation Is Back In the Spotlight
-
What a Strong Economy Now Means for the Rest of 2024
-
10 Top Dividend Stocks for 2024
-
Finding Small-Cap Stock Opportunities In a Big-Cap World
-
The 10 Best Companies to Invest in Now
-
Nike Earnings: Dim Sales Outlook Slams Shares, but Patient Investors Could Be Rewarded
-
2 Top E-Commerce Stock Picks
-
Our Top Pick for Investing in US Renewable Energy
-
Micron Earnings: We Raise Our DRAM Forecast and Valuation Behind Stronger Pricing Assumptions
-
10 Undervalued Wide-Moat Stocks